Who We Are
We are an international CRO. We specialise in human health research.
Pharmalys is a Contract Research Organisation founded in London in 2008, with extensive experience leading the design, execution and reporting of clinical trials to global regulatory and ethical standards across Europe.
In 2012, we expanded to West Africa, establishing our regional headquarters in Dakar, Senegal, to deliver high quality clinical research operations to Sub-Saharan Africa.
Key Figures
We operate in 30+ countries
50+ ethics committees and regulatory authorities strengthened
120+ graduates trained
300+ site staff supported, leading to stronger site readiness, and sponsor confidence
Our Brand Promise
We help advance health
through data excellence
- We specialise in public health, clinical and epidemiological research.
- We have a strong track record of collaborating with both private and public partners globally.
- We contribute to the collection, management and reporting of robust and reliable data that impact people’s lives around the world.
Services

Clinical Monitoring

Project Management

Regulatory Affairs

Quality Assurance
Our identity
Our Solutions

Interventional Studies
Planning and execution of your early stage trials to ensure timely completion of your clinical development programmes.

Capacity Building

Observational Studies

Implementation Research
Latest News
Successful GCLP Audit at KEMRI–Wellcome Trust Research Programme, Kilifi
We are pleased to announce the successful completion of a GCLP audit at the KEMRI–Wellcome Trust Research Programme facility in Kilifi, Kenya, conducted on 6-7 November 2025. The audit was led by Patrick Karugaba and covered a wide range of laboratory areas, including...
World Neglected Tropical Diseases Day 2026 | 30 January
Neglected tropical diseases remain a daily reality for more than one billion people worldwide. Yet they are among the most solvable challenges in global health. With proven tools, coordinated action, and sustained commitment, NTDs can be prevented, treated, and...
January 2026 Newsletter: Happy New Year from Pharmalys!
We hope you all enjoyed a restful festive period and feel energised for the year ahead. At Pharmalys, we enter 2026 with the same sense of readiness and purpose, having wrapped up 2025 with our Annual Meeting (pictured above), which provided an opportunity to reflect...



